The vaccine becomes the fifth to be approved for use in the country after the Chinese Sinopharm and Sinovac, the Russian Sputnik V and the Indian Covaxin.
MCAZ spokesperson Mr Shingirai Gwatidzo said the emergency use authorisation issued to the
The
"MCAZ reviewed the technical documentation and clinical studies conducted and issued Emergency Use Authorisation for
"This EUA is subject to a number of considerations which include ensuring there is adequate cold storage capacity to store the vaccines and also ensuring there is robust side effect monitoring in place to monitor for potential side effects," said
He said the Ministry of Health would then decide whether to deploy the vaccines in
"Our responsibility is to ensure that we conduct the risk-benefit analysis prior to issuance of the EUA," he said.
The
Copyright The Herald. Distributed by AllAfrica Global Media (allAfrica.com)., source